S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
25 Ways to Improve Your Financial Situation in 1 Hour
La-Z-Boy Reclines To More Comfortable Levels 
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Are the Short Sellers Still Right About Mullen Automotive stock? 
Is The Recovery Rally Here For SoFi?
Defy EOY Volatility with Artificial Intelligence (Ad)pixel
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
NASDAQ:CRON

Cronos Group - CRON Stock Forecast, Price & News

$3.26
+0.15 (+4.82%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.14
$3.28
50-Day Range
$2.71
$3.36
52-Week Range
$2.57
$4.73
Volume
2.16 million shs
Average Volume
2.08 million shs
Market Capitalization
$1.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.09

Cronos Group MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
25.5% Upside
$4.09 Price Target
Short Interest
Healthy
4.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.90mentions of Cronos Group in the last 14 days
Based on 9 Articles This Week
Insider Trading
Acquiring Shares
$458,313 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.29) to ($0.19) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

Medical Sector

365th out of 1,047 stocks

Medicinals & Botanicals Industry

3rd out of 15 stocks

CRON stock logo

About Cronos Group (NASDAQ:CRON) Stock

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Stock News Headlines

Analysts Set Cronos Group Inc. (NASDAQ:CRON) Price Target at $4.07
Here's Why I'm Closing My Crypto.Com Account in 2023
Why Cardano, Chainlink, and Cronos Are Slumping Today
Matt Damon Crypto.com's Coin Is in Free Fall
Cronos Group: There Are Green Shoots Amid The Weeds
Cronos Group Reports 2022 Third Quarter Results
Better Buy: Canopy Growth vs. Cronos Group
Are Canadian Penny Stocks Ready To Rebound?
Ginkgo Bioworks: Business Model Uncertainty
Canadian Shares Rising Sharply After Slightly Weak Start
Cryptocurrencies To Watch: Week of September 26
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

CRON Company Calendar

Last Earnings
11/07/2022
Today
12/02/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/07/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
626
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.09
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+25.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-396,110,000.00
Net Margins
-235.72%
Pretax Margin
-234.01%

Debt

Sales & Book Value

Annual Sales
$74.43 million
Book Value
$3.15 per share

Miscellaneous

Free Float
355,834,000
Market Cap
$1.23 billion
Optionable
Optionable
Beta
1.55

Key Executives

  • Mr. Michael Ryan Gorenstein J.D.Mr. Michael Ryan Gorenstein J.D. (Age 35)
    Pres, CEO & Chairman
    Comp: $389.15k
  • Ms. Shannon Buggy (Age 52)
    Sr. VP & Global Head of People
    Comp: $438.81k
  • Ms. Anna Shlimak (Age 36)
    Sr. VP of Corp. Affairs & Strategy
    Comp: $422.03k
  • Mr. James Holm
    Chief Financial Officer
  • Mr. Carlos Cortez (Age 49)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 32)
    Sr. VP of Legal & Regulatory Affairs and Corp. Sec.
  • Mr. Jeffrey David Jacobson (Age 36)
    Chief Growth Officer
  • Mr. Arye Weigensberg
    Head of R&D
  • Mr. Kevin B Gifford
    VP of Fin.













CRON Stock - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CRON shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price forecast for 2023?

8 brokerages have issued 12 month price targets for Cronos Group's shares. Their CRON share price forecasts range from $3.00 to $7.00. On average, they anticipate the company's stock price to reach $4.09 in the next twelve months. This suggests a possible upside of 25.5% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2022?

Cronos Group's stock was trading at $3.92 at the beginning of the year. Since then, CRON stock has decreased by 16.8% and is now trading at $3.26.
View the best growth stocks for 2022 here
.

Are investors shorting Cronos Group?

Cronos Group saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 8,800,000 shares, a decrease of 7.6% from the October 31st total of 9,520,000 shares. Based on an average daily volume of 1,840,000 shares, the days-to-cover ratio is currently 4.8 days. Approximately 4.5% of the shares of the company are sold short.
View Cronos Group's Short Interest
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our CRON earnings forecast
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) released its earnings results on Monday, November, 7th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The business earned $20.92 million during the quarter, compared to analysts' expectations of $23.30 million. Cronos Group had a negative trailing twelve-month return on equity of 16.29% and a negative net margin of 235.72%.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by many different institutional and retail investors. Top institutional investors include ETF Managers Group LLC (2.45%), Vanguard Group Inc. (1.71%), Group One Trading L.P. (0.00%), Dimensional Fund Advisors LP (0.29%), Citadel Advisors LLC (0.00%) and NewGen Asset Management Ltd (0.20%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends
.

How do I buy shares of Cronos Group?

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $3.26.

How much money does Cronos Group make?

Cronos Group (NASDAQ:CRON) has a market capitalization of $1.23 billion and generates $74.43 million in revenue each year. The company earns $-396,110,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How many employees does Cronos Group have?

The company employs 626 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004.

This page (NASDAQ:CRON) was last updated on 12/2/2022 by MarketBeat.com Staff